Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

The microglial sensome revealed by direct RNA sequencing.
JCV GCN in a natalizumab-treated MS patient is associated with mutations of the VP1 capsid gene.
Comment on the letter by Messori et al. (European Journal of Neurology 2013; 20: e131).
Current and future drugs for treatment of MS-associated bladder dysfunction.
Multiple Sclerosis: Validation of MR Imaging for Quantification and Detection of Iron.
[Multiple sclerosis: new approaches to comprehensive treatment and rehabilitation using the method of reflexology].
Evaluation of a multiparametric immunofluorescence assay for standardization of neuromyelitis optica serology.
T cell-intrinsic ASC critically promotes TH17-mediated experimental autoimmune encephalomyelitis.
Safety and efficacy of fingolimod in treatment-naïve multiple sclerosis patients.
Treatment of human spasticity with delta 9-tetrahydrocannabinol.
Molecular Mechanisms Underlying the Effects of Statins in the Central Nervous System.
Emerging tumefactive MS after switching therapy from interferon-beta to fingolimod: A case report.
Successful desensitization to natalizumab in a skin test--positive patient: a case report.
Coping strategies and mood profiles in patients with multiple sclerosis.
Riluzole inhibits the release of glutamate in the caudate nucleus of the cat in vivo.
Prevalence of dysphagia in multiple sclerosis: a systematic review and meta-analysis.
Association between multiple sclerosis and chronic periodontitis: a population-based pilot study.
Integration of MicroRNA Databases to Study MicroRNAs Associated with Multiple Sclerosis.
Physiotherapy as an immunoactive therapy? A pilot study.
CCSVI and MS: no meaning, no fact.
Behçet's Disease Presenting with Acute Transverse Myelitis: MRI Findings and Review of the Nosology. A Case Report.
Testing the feasibility and acceptability of using the Nintendo Wii in the home to increase activity levels, vitality and well-being in people with multiple sclerosis (Mii-vitaliSe): protocol for a pilot randomised controlled study.
Fingolimod reduces recurrence of disease activity after natalizumab withdrawal in multiple sclerosis.
Cortical lesion load correlates with diffuse injury of multiple sclerosis normal appearing white matter.
Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica.

Pages